Fpr Partners LLC Kodiak Sciences Inc. Transaction History

Fpr Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $27.2 Million - $44.6 Million	-352,505 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $7.38 Million - $18.7 Million	121,493 Added 52.59%	352,505 $51.8 Million
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $10.4 Million - $13.7 Million	231,012 New	231,012 $13.7 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Fpr Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Fpr Partners LLC with notifications on news.